Phillips-Medisize to Highlight Connected Health Innovations Including its Complete Ecosystem at Pharmapack 2019
Summary
“Our proven expertise and strong knowledge base spans drug delivery applications – from feasibility to selecting the right components through commercial scale production, including electronics integration and cloud-based solutions.” In addition, Phillips-Medisize offers technology accelerators (customizable building blocks for drug delivery devices) to expedite product development time and give pharmaceutical companies a competitive edge. “Our connected health solutions are easily tailored to unique applications and work seamlessly with digital interfaces such as patient and caregiver apps, portals and dashboards. Phillips-Medisize, LLC, a Molex company, is an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics, and medical device market segments. Backed by the combined global resources of Molex and its parent company Koch Industries, Phillips-Medisize’s core advantage is the knowledge of its people to integrate design, molding, electronics, and automation, providing innovative, high-quality manufacturing solutions.